Vapouround magazine ISSUE 11 | Page 89

F E AT U R E The most clear and present problems on liability for vaping lie in unreliable devices. There are also significant, ongoing issues with mislabelled products, another liability vulnerability for vape businesses. Manufacturers are more legally responsible than distributors Insurance complications defined the day’s main talk on business, When Steve Green of Anthony Jones Insurance Brokers took to the stage, we were treated to invaluable advice from a keen, experienced financial mind. Anthony Jones Insurance Brokers may have been media partners for the event, but were also able to bring the full expertise and detached objectivity of a fully-grown industry outside of vaping. “In insurance terms, vaping is a very, very young entity,” he said. “That newness, that uncertainty means potentially shaky confidence for insurers. “The most clear and present problems on liability for vaping lie in unreliable devices. There are also significant, ongoing issues with mislabelled products, another liability vulnerability for vape businesses. Manufacturers are more legally responsible than distributors.” Steve acknowledged that much of this was due to ubiquitous and often unfairly negative media coverage of malfunctioning devices. “Mod safety is improving – accidents caused by exploding batteries via faulty chargers is falling and products are improving across the board. “The biggest cause of battery and mod failure is user error – an extremely difficult defence to put forward in court when faced with an injured party. The image of a company going against an individual in such a situation isn’t a sympathetic one and won’t engender good media coverage.” With Steve Green’s eye-opening talk fresh in everyone’s minds, the floor was handed over to four additional figureheads and authorities in matters of business: Cuts Ice CEO Nigel Quine; Malcolm Keen, Solicitor of BLM Law – the UK’s leading insurance and risk law specialists; Jac Vapour CEO Neil McCallum and Stuart Mathieson of WTC Logistics. Malcolm Keen continued the advice on what vape companies should consider on matters of insurance. He said potential divided the basics into three parts: insurance claims begin with identification of loss and damage, develop with assessment of how loss changes with a claim, and conclude with a defence. Malcom pointed out that “there has never been a successful secondary smoke claim” made against vaping, and that though we see a 96-96% harm reduction compared to smoking, some influential bodies are prolonging certain debates, such as popcorn lung claims. “Claims rely on proof of causation; proofs of pulmonary disorder or other reactive diseases are almost impossible but claimants will still attempt them. Public Health England agreed in 2016 that health risks in e-cigarettes are minimal compared to combustibles, but long-term effects are still being observed.” The talk also contained warnings against short-term, myopic thinking and the temptations of quick fixes: Business matters and Brexit are joined at the hip in today’s landscape, but Neil McCallum urged us not to let it distract from our mission: “Thousands and thousands of small elements on all things related to business will be affected by Brexit, but unless we get vaping separate from tobacco we’ll never establish our own identity in the market and insurance companies won’t be able to accurately and impartially assess us for claims, cases and coverage.” “Merely selling insurance to vape retailers is not an adequate fix for problems in this field.” Nigel Quine said it was vital that an opportunity was not missed to free millions of people from smoking tobacco. There are bigger problems on the horizon, many of them tied to the consequences of vaping being misidentified as tobacco-associated. “Our top priority must be separating tobacco from vaping in the public eye,” “Without a doubt, manufacturers and retailers in all regions will be subject to future tobacco litigation.” Steve predicted the EU would again move toward classification of e-cigarettes as medicinal products. There are also numerous class action lawsuits brewing in the American legal system to be wary of; tremors in the world’s largest vape market will have a domino effect. Steve advised vape businesses research these lawsuits on www.schmidtandclark.com and www.classaction.com he said. We have an opportunity to free millions from smoking and can’t let this product of ours be legislated away from its potential. When this happens, we lose valuable time that could be spent advancing and perfecting vapour products and expanding their reach.” VAPOUROUND MAGAZINE ISSUE 11 89